The diagnostic accuracy of Quantiferon-TB Gold In-Tube (QFT-IT) is uncertain in the pediatric population, while tuberculin skin test (TST) is still conventionally used despite its limitations. The aim of this study was to compare the performance of QFT-IT with TST in a large cohort of children screened for tuberculosis (TB) infection because of contact tracing, suspected TB, arrival from endemic country or immunosuppressive therapy. Methods: A retrospective analysis was conducted on 517 children 0-14 years of age evaluated at the pediatric unit of the S. Orsola-Malpighi University Hospital of Bologna, Italy; 366 of them were also tested with TST. Results were analyzed for Calmette-Guérin bacillus vaccination, country of origin, reason for testing, diagnosis and age. Results: The overall agreement between the 2 tests was 89.9%, but it was highly affected by Calmette-Guérin bacillus vaccination (P < .0001). According to diagnosis and age, QFT-IT detected latent tuberculous infection cases better than TST in all age groups. Sensitivity for diagnosing active TB in symptomatic children was higher for QFT-IT than TST (93.3% vs. 86.5%), especially in children younger than 2 years, while specificity was high for both tests (99.3% and 98.8%, respectively). Low rate of indeterminate QFT-IT results (3.9%) was not differently distributed among age groups, but was associated with diagnosis of TB exclusion (P < 0.0001), mainly pneumonia (35%), and to Italian children (P = 0.0024).
D
iagnosis of active tuberculosis (TB) in children is complicated by various factors. Children exhibit nonspecific clinical presentation, less cavitation and fewer bacilli than adults and are more likely to have extrapulmonary TB. [1] [2] [3] [4] Diagnostic tests for microbiologic confirmation of active disease are less sensitive than in adults. Multiple biologic sampling and combination of molecular and immunologic methods have been proposed to increase diagnostic sensitivity. [5] [6] [7] [8] At the same time, after exposure to an active TB case, children are at a higher risk of developing severe disease than adults; hence, contact tracing and chemoprophylaxis of latent TB infection (LTBI) are mandatory. 9 Until recently tuberculin skin test (TST) was the main diagnostic method to detect Mycobacterium tuberculosis (MTB) infection. However TST has several limitations: sensitivity can be influenced by child's age and immunologic status leading to false negative, and specificity suffers cross-reaction with Calmette-Guérin bacillus (BCG) vaccination or nontuberculous mycobacteria infections leading to false positive. 10, 11 Interferon-gamma (IFN-γ) release assays (IGRAs) have been used extensively for the diagnosis of TB infection since 2001 and have become useful additional tests in the diagnosis of active TB in adults. They rely on IFN-γ release by effector memory T cells stimulated with specific MTB antigens (ESAT-6, CFP-10 and TB7.7) absent from the Mycobacterium bovis BCG strains and most environmental mycobacteria, and on the presence of a control of the immune reactivity. Overall, IGRAs are more specific than TST, preventing unnecessary treatment, correlate better with TB exposure, and are more sensitive in diagnosing TB, at least in settings in which the prevalence of the disease is low. [12] [13] [14] Meta-analysis and targeted studies about the diagnostic accuracy of IGRAs in children are increasing. [15] [16] [17] [18] [19] [20] [21] [22] [23] However main concerns regard their immature immune system and the discrepant proportions of indeterminate results reported in different studies. [24] [25] [26] [27] Nowadays the available evidence does not support using an IGRA as an alternative to a TST; nevertheless several national guidelines now recommend the use of IGRA, alone or in combination with TST, in screening algorithms for LTBI. 28, 29 In addition TST and QFT-IT can have an additional value in diagnosing active TB in children as the probability of bacteriologic confirmation is usually low.
The aim of this study was to evaluate the performance of Quantiferon-TB Gold In-tube (QFT-IT), a commercially available IGRA, in a large group of children and its concordance with TST by BCG vaccination status, country of origin, reason for testing, diagnosis and age.
MATERIALS AND METHODS

Study Design
This was a 5-year retrospective analysis of QFT-IT results according to final diagnosis of children from 0 to 14 years old attending the S. Orsola-Malpighi University Hospital in Bologna, Italy, a low TB endemic country with high immigration rates from middle and high TB prevalence countries.
Inclusion criteria were having undergone a QFT-IT test for the following reasons: TB screening for recent arrival (less than 6 months) from a TB endemic country, contact tracing of an active TB case, suspected active TB and TB screening before immunosuppressive therapy. After informed consent, 30 children were also tested as negative controls during blood drawing for other reasons not related to infectious disease or immunosuppressive conditions within a prospective study on QFT-IT; they were not tested with TST.
Demographic and clinical information were collected from the medical files of the children, including origin of the family, place of birth and BCG vaccination status.
The study protocol was approved by the Research Ethics Committee of S. Orsola-Malpighi University Hospital.
Microbiologic Diagnosis of Active TB
When active TB was suspected, a multiple sampling approach was adopted according to Al-Aghbari et al. 5 Consecutive biologic samples were collected from respiratory tract (sputum, gastric lavage, aspiration of upper respiratory airways) and/or from extrapulmonary sites according to the suspected localization. Samples were examined by light smear microscopy (Ziehl-Neelsen staining) and molecular system GeneXpert MTB/RIF (Cepheid, Sunnyvale, CA) which simultaneously detects the presence of MTB genome and resistance to rifampicin.
MTB was isolated using solid (Lowenstein-Jensen; Heipha Diagnostika Biotest, Heidelberg, Germany) and liquid culture (MGIT; Becton Dickinson, Franklin Lakes, NJ). Drug susceptibility test to first-line drugs (streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide) was performed by the automatic MGIT 960 system (Becton Dickinson).
Quantiferon-TB Gold In-Tube
QFT-IT assay (Cellestis, Melbourne, Australia) was performed and interpreted according to the manufacturer's instruction. 30 Briefly, venous blood was collected in 3 distinct tubes: one containing MTB-specific Antigens (ESAT-6, CFP-10 and TB7.7), one with a nonspecific Mitogen (phytohemoagglutinin) as positive control of immune system reactivity and an empty tube (Nil) as negative control for IFN-γ background value. The tubes were incubated at 37°C for 18 hours and, after centrifugation, the IFN-γ released was measured by enzyme-linked immunosorbent assay and converted to international units/mL (IU/mL). Tubes that were not analyzed immediately were stored at 4°C. Positive results were defined as Nil-subtracted Antigen value being above 0.35 IU IFN-γ/mL. If the Nil-subtracted Mitogen value was <0.50 IU/mL and/ or if the Nil value was >8.0 IU/mL, the test was considered indeterminate.
Test failure due to incorrect blood volume and time of blood draw was very low (<1%); failed samples were repeated.
Tuberculin Skin Test
Children received TST using 2 units of purified protein derivate (RT 23, Statens Serum Institute, Copenhagen, Denmark) using the Mantoux method. TST indurations were measured by palpation 48-72 hours later and were graded negative (<5mm), intermediate (≥5 and <10 mm) and positive (≥10 mm) according to the Red Book guidelines.
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Diagnostic Group Definition
Participants were categorized into 5 groups according to clinical outcome reported in their medical files.
Children were defined as having active TB according to the diagnosis made by the physician following WHO criteria. 1 This category included microbiologically confirmed cases, based on culture and/or GeneXpert positivity, and clinically confirmed cases if diagnosis was based on clinical, pathologic and radiologic findings consistent with the disease and no improvement after a full course of antibiotics, followed by clinical improvement with anti-TB treatment. All children with a diagnosis of active TB were therefore followed up until recovery. Children were categorized as TB excluded if, after undergoing QFT-IT for signs and symptoms suggestive of TB, with or without TST, active disease was excluded and another diagnosis was made at the end of investigation and treatment. According to national recommendations, 29 children in contact with adults with active tuberculosis, children who have recently arrived from a TB endemic area before admission to school and those undergoing immunosuppressive therapy were referred to the Pediatric Unit and underwent a history investigation, including BCG vaccination status, clinical assessment, chest x-ray, immunologic and microbiologic assays. After excluding active TB, children were categorized as having LTBI based on the physician's decision after evaluating QFT and TST results, risk of exposure, BCG status and origin at the first investigation and after 3 months. All children diagnosed with LTBI were offered prophylaxis with isoniazid and followed up for 12 months. Children with risk factors for TB (contact tracing or recent arrival from a TB endemic country) with a negative result at the first investigation and confirmed negativity after 3 months were defined as exposed.
Children were excluded from the analysis if the outcome was not specified or if they had a history of having been previously treated for TB.
Statistical Analysis
Comparisons between QFT-IT and TST results according to origin, BCG vaccination status, reason for testing, diagnosis and age group were performed by χ 2 test or by χ 2 test for trend when appropriate. For the assessment of diagnostic agreement between tests, Cohen's κ statistics were calculated when possible. McNemar test was used to compare sensitivity and specificity values.
Statistical analysis was performed using (Stata SE 14.1 College Station, TX). Statistical significance was set at P < 0.05. All P values were 2 tailed.
RESULTS
Description of the Study Population
A total of 551 children had a QFT-IT result available. Thirtyfour children were excluded from the analysis because of incomplete diagnosis or history of previous TB treatment. Among the remaining 517 children, 288 (55.7%) were males and 229 (44.3%) were females, and mean age was 5.4 ± 4.0 years. Ninety-eight children (18.9%) were born in countries with middle or high prevalence of TB according to WHO definition. 32 Of the 412 (79.7%) children born in Italy or another low-prevalence country, 197 (38.1%) belonged to a family originally from a country with middle or high prevalence. Origin of the family was not known for 7 (1.3%) of the Italy-born children. Of the 451 children (87.2%) with a known BCG status, 50 had been vaccinated (11.1%).
Reason for testing, BCG vaccination and the final diagnosis are summarized in Table 1 . One hundred seventy-six (34.1%) children underwent QFT-IT for suspicion of active TB, 258 (49.9%) for contact tracing, 42 (8.1%) for recent arrival from a TB endemic country and 11 (2.1%) for routine screening before immunosuppressive treatment. Thirty (5.8%) children were also included as negative controls.
The final diagnosis was active TB in 45 children (8.7%), TB excluded in 159 (30.7%), LTBI in 38 (7.4%) and exposed in 245 (47.4%). Among TB excluded, the most frequent diagnosis
Description of QFT-IT and TST Results
Of 
Agreement Between QFT-IT and TST
QFT-IT and TST results, test agreement and distribution of concordant and discordant results were analyzed according to family origin, BCG vaccination status, reason for testing and final diagnosis (see Table, Supplemental Digital Content 1, http://links.lww. com/INF/C541). Furthermore QFT-IT performance was analyzed according to age; participants were divided into 4 age groups: 109 (21.1%) children were 0-1.9 years old, 173 (33.5%) were 2-4.9 years old, 154 (29.8%) were 5-9.9 years old and 81 (15.6%) were 10-14 years old.
Overall, agreement between tests was 89.9% with good concordance (K = 0.68). Fifty-three children had QFT+/TST+ and 276 QFT−/TST− concordant results, while 23 had QFT−/TST+ and 14 QFT+/TST− discordant results.
Agreement between tests was good for children born in Italy, regardless of the origin of the family while it was fair in children born in middle and high TB prevalence countries. In the latter category, 19 of 22 discordant results were QFT−/TST+, 18 of whom were BCG vaccinated.
When agreement was analyzed according to BCG status (41.7%), vaccinated children were more likely to have a positive TST than children who were not vaccinated (60.9% and 11.9%, respectively, P < 0.0001), while the proportion of positive QFT-IT in the 2 groups was not statistically different (18.0% and 13.5%, respectively).
When reason for testing was considered, agreement between tests was high in cases of suspected TB (96.1%) and contact tracing (94.2%), while it was low (42.8%) in cases of screening new arrivals. In this category, 19 of 20 discordant results were QFT−/TST+, 16 of whom were BCG vaccinated. Agreement among negative controls was not calculated because they were not tested with TST. They were all QFT negative except one that was indeterminate.
After a final diagnosis was established, agreement between tests was high in cases where TB was excluded (97.7%). Agreement was good in children with diagnosis of exposure (90.9%), with 17 of 19 QFT−/TST+ discordant cases BCG vaccinated. Agreement was moderate in children with active TB (86.0%), with discordant cases mainly because of QFT+/TST− results (n = 4).The low agreement (66.7%) in children with LTBI was due to 9 QFT+/ TST− while 2 cases had QFT−/TST+ results.
When agreement was analyzed according to age, no difference was found among the age groups. Concordant QFT+/TST+ results showed an increasing trend (P = 0.0022), rising from 6.3% among the 0-1.9 years old, to 12.6% (2-4.9 years old), 17.5% (5-9.9 years old) and 24.1% (10-14 years old).
To further investigate the relationship between age and diagnosis of active and latent TB, QFT-IT and TST results were reported according to age group and agreement was calculated for paired tests (Table 2 ). In children younger than 2 years, agreement between the 2 tests was low for diagnosis of both active TB and LTBI (57.1% and 33.3%, respectively) because of discordant QFT+/ TST− (3 and 2 cases, respectively). In children older than 2 years, the 2 tests showed comparable results for diagnosis of active TB and agreement was high (81.8%-100%). In contrast for LTBI diagnosis, agreement was low (66.7%-73.3%): among 9 children with discordant results, 7 were QFT+/TST− and 2 were QFT−/TST+.
QFT-IT and TST Sensitivity and Specificity in Symptomatic Patients
Specificity and sensitivity of QFT-IT and TST in diagnosing active TB were calculated comparing participants with active TB to those with symptoms and/or signs of TB but with a final diagnosis of TB exclusion. Patients with LTBI were excluded from this analysis as test results were an intrinsic part of the definition of LTBI cases, and no standard exists to compare the performance of each technique.
One hundred forty-eight patients had symptoms of suspected active TB at enrolment, but active TB was excluded and an alternative diagnosis was made. Among them, 14 had an indeterminate QFT-IT result and were excluded from further analysis.
Of the 45 patients who had a final diagnosis of confirmed active TB either microbiologically (n = 22) or clinically (n = 23), 25 underwent tests for symptoms suggestive of active TB, while 20 were diagnosed as having active TB during clinical evaluation for contact tracing (n = 18) or recent arrival from high-prevalence country (n = 2).
There were no significant differences in the overall sensitivity between QFT-IT (93.3%) and TST (86.5%; Table 3 ).
Among microbiologically confirmed TB, QFT-IT gave positive results in 21 of 22 (95.5%) cases and TST in 13 of 14 (92.9%) cases; in clinically confirmed cases, QFT-IT was positive in 21 of 23 (91.3%) cases, while TST was positive in 19 of 23 (82.6%) cases.
According to localization, 35 cases had pulmonary disease with a positive QFT-IT in 32 of 35 (91.4%) cases, while TST resulted positive in 26/30 (86.7%) cases; in 10 extrapulmonary diseases, QFT-IT was positive in all cases while TST in 6 of 7 (85.7%) cases.
In children younger than 2 years with active TB, QFT-IT sensitivity [100%, 95% confidence interval (CI): 63.1%-100%] was significantly higher than TST sensitivity (57.1%, 95% CI: 18.4%-90.1%; P = 0.0454). In children older than 2 years, sensitivity was high for both tests with no significant differences. In particular, QFT-IT sensitivity ranged from 91.7% to 92.3%, while TST sensitivity ranged from 90.9% to 100% among different age groups.
Overall, specificity was high for both tests (99.3% and 98.8% for QFT-IT and TST, respectively) and it was not affected by age group.
Indeterminate QFT-IT Results
Overall, 20 (3.9%) patients had indeterminate QFT-IT results. No indeterminate result was found in patients diagnosed as having active TB or LTBI, while indeterminate results were strongly associated with the category "TB excluded" with other diagnosis (18 cases, 90%, P < 0.0001). Six of 22 (27.3%) patients with autoimmune or neoplastic disease, 7 of 41 (17.1%) with pneumonia, 3 of 25 (12.0%) with acute nonrespiratory infections, 1 of 16 (6.3%) with acute respiratory infections and 1 of 31 (3.2%) non-TB lymphadenopathy had an indeterminate QFT result. The 2 remaining indeterminate QFT-IT results occurred in 1 of 245 (0.4%) patients diagnosed as exposed and in 1 of 30 (3.3%) negative controls. Therefore, among children with indeterminate results, pneumonia were diagnosed in 35% and autoimmune or neoplastic disease in 30% of cases. Table 4 describes the clinical characteristics of the children scored indeterminate to QFT-IT.
As shown in Table, Supplemental Digital Content 1, http:// links.lww.com/INF/C541, indeterminate QFT-IT results were not affected by age because proportions were stable among the different age groups: 3.7% in the 0-to 1.9-year-olds, 5.2% in the 2-to 4.9-year-olds, 3.2% in the 5-to 9.9-year-olds and 2.4% in the 10-to 14-year-olds. Indeterminate results were influenced by origin and they were more frequently seen in Italian children (P = 0.0024). All the indeterminate results were due to low Mitogen, but one was due to high Nil and had a final diagnosis of enteritis caused by rotavirus.
A TST result was available in 6 cases with indeterminate QFT-IT and all results were negative.
In 3 patients with indeterminate QFT-IT result, the test was repeated within a month, 2 of them were negative and 1 remained indeterminate.
DISCUSSION
This study analyses QFT-IT performance and its concordance with TST in a cohort of 517 children 0-14 years of age, who underwent the test for suspected active TB, contact tracing, recent arrival from endemic areas or as screening before immunosuppressive therapy.
Overall, agreement among the tests was high, but it decreased among children recently arrived in Italy from an endemic country. In this population, most disagreement was in BCG-vaccinated children who had QFT-IT−/TST+ results, consistently with the widely reported low specificity of TST in this category. 10, 11 Agreement between the tests was moderate in children with active TB (86.0%), with sensitivity being higher for QFT-IT than TST (93.3% vs. 86.5%). The highest difference between tests was seen in children younger than 2 years for which QFT was positive in 100% of cases and TST in 57.1%. Even though the number of children included in the subanalysis is limited, this finding is coherent with a recent multicenter Italian study showing similar results and supporting the use of this test even in infants. 33 Analysis of performance of the 2 tests in LTBI diagnosis is hampered by the lack of a standard and the somewhat controversial definition of LTBI. 18 In our study, the physician based the final decision of having LTBI or not on risk of exposure, BCG status, QFT-IT result and magnitude of TST reaction. Even though the diagnose might have been biased, 34 of 38 children (89.5%) diagnosed as having LTBI who were positive to QFT-IT, had at least one risk factor for TB infection (known TB exposure, being born in a TB-endemic country or having parents born in a TBendemic country). In contrast, sensitivity of TST in diagnosing LTBI was lower (65.0%) than QFT-IT: 11 children who underwent contact tracing tested QFT-IT+/TST− and they would have been labeled not infected if TST were the only criteria, increasing the risk of progression to active disease because of missed prophylaxis. A further analysis of TST results showed that all 19 children with discordant QFT−/TST+ that were labeled as exposed had a TST ≤ 15 mm and were BCG vaccinated, while the 2 children who were labeled LTBI and had QFT−/TST+ discordant result had TST > 15 mm.
The overall rate of indeterminate QFT-IT results in the cohort was low (3.9%) as reported in previous studies. 18, [33] [34] [35] [36] [37] Indeterminate results were mostly distributed among non-TB acute infections, with pneumonia accounting for 35% of the cases, in agreement with other studies. 18, 38 A recent report from Jeljeli et al 39 showed that low IFN-γ production in response to mitogen in immunocompetent children with other ongoing infectious diseases, such as pneumonia, is accompanied by impaired Th1, Th2, Th17 immune response.
Although previous studies reported that IFN-γ release in response to mitogen is significantly affected by age, [40] [41] [42] we saw no differences in indeterminate results among age groups, suggesting that immune system is not impaired in its ability to mount an immune response even in young children.
The results of the study are limited by the retrospective design and the relatively small number of children in the subgroups analyzed.
This study suggests that QFT-IT performs better than TST in diagnosing latent and active TB in children, especially in children younger than 2 years and in those that are BCG-vaccinated. The low rate of indeterminate results does not limit QFT-IT usage in infants. Therefore it seems reasonable to encourage the use of QFT-IT as a complementary test for the diagnosis and management of TB in children.
